BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 284199)

  • 1. The indole hallucinogens, N,N-dimethyltryptamine (DMT) and 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT), have different effects from mescaline on rat shuttlebox avoidance.
    Stoff DM; Gorelick DA; Bozewicz T; Bridger WH; Gillin JC; Wyatt RJ
    Neuropharmacology; 1978 Dec; 17(12):1035-40. PubMed ID: 284199
    [No Abstract]   [Full Text] [Related]  

  • 2. Dose response and time course effects of N,N-dimethyltryptamine on disruption of rat shuttlebox avoidance.
    Stoff DM; Moja EA; Gillin JC; Wyatt RJ
    Biol Psychiatry; 1977 Jun; 12(3):339-46. PubMed ID: 266950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The behavioural effects of some derivatives of mescaline and N,N-dimethyltryptamine in the rat.
    Smythies JR; Bradley RJ; Johnston VS; Leonard F
    Life Sci; 1967 Sep; 6(17):1887-93. PubMed ID: 6052683
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of N,N-dimethyltryptamine (DMT) and 5-methoxy-N,N-dimethyltryptamine (5-MeODMT) on shock elicited fighting in rats.
    Walters JK; Sheard MH; Davis M
    Pharmacol Biochem Behav; 1978 Jul; 9(1):87-90. PubMed ID: 279938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral effects and physiological disposition of some beta-hydroxylated indoleamines in the rat.
    Gentile NT; Friedman HA; Vogel WH
    Biol Psychiatry; 1982 Jan; 17(1):109-13. PubMed ID: 6800414
    [No Abstract]   [Full Text] [Related]  

  • 6. Opposite effects of N,N-dimethyltryptamine (DMT) and 5-methoxy-n,n-dimethyltryptamine (5-MeODMT) on acoustic startle: spinal vs brain sites of action.
    Commissaris RL; Davis M
    Neurosci Biobehav Rev; 1982; 6(4):515-20. PubMed ID: 6817240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hallucinogens as a discriminative stimuli: generalization of DOM to a 5-methoxy-N, N-dimethyltryptamine stimulus.
    Glennon RA; Rosecrans JA; Young R; Gaines J
    Life Sci; 1979 Mar; 24(11):993-7. PubMed ID: 286864
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparison of stimulants and hallucinogens on shuttle avoidance in rats.
    Davis WM; Hatoum HT
    Gen Pharmacol; 1987; 18(2):123-8. PubMed ID: 3569841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disruption of conditioned avoidance behavior by n,n-dimethyltryptamine (DMT) and stereotype by beta-phenylethylamine (PEA): animal models of attentional defects in schizophrenia.
    Stoff DM; Moja EA; Gillin JC; Wyatt RJ
    J Psychiatr Res; 1978; 14(1-4):225-40. PubMed ID: 281530
    [No Abstract]   [Full Text] [Related]  

  • 10. 5-Methoxy-N,N-dimethyltryptamine: behavioral and toxicological effects in animals.
    Gillin JC; Tinklenberg J; Stoff DM; Stillman R; Shortlidge JS; Wyatt RJ
    Biol Psychiatry; 1976 Jun; 11(3):355-8. PubMed ID: 820383
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of a hallucinogen, 5-methoxy N,N-dimethyltryptamine, on primate social behavior.
    Schlemmer RF; Narasimhachari N; Thompson VD; Davis JM
    Commun Psychopharmacol; 1977; 1(2):105-18. PubMed ID: 414877
    [No Abstract]   [Full Text] [Related]  

  • 12. The role of 5-HT2A, 5-HT 2C and mGlu2 receptors in the behavioral effects of tryptamine hallucinogens N,N-dimethyltryptamine and N,N-diisopropyltryptamine in rats and mice.
    Carbonaro TM; Eshleman AJ; Forster MJ; Cheng K; Rice KC; Gatch MB
    Psychopharmacology (Berl); 2015 Jan; 232(1):275-84. PubMed ID: 24985890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for and against the involvement of N,N-dimethyl-tryptamine (DMT) and 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) in schizophrenia.
    Gillin JC; Wyatt RJ
    Psychopharmacol Bull; 1976 Oct; 12(4):12-3. PubMed ID: 1067623
    [No Abstract]   [Full Text] [Related]  

  • 14. Structure activity relations of some indolealkylamines in comparison to phenethylamines on motor activity and acquisition of avoidance behavior.
    Vasko MR; Lutz MP; Domino EF
    Psychopharmacologia; 1974 Mar; 36(1):49-58. PubMed ID: 4525044
    [No Abstract]   [Full Text] [Related]  

  • 15. Interactions of hallucinogens at the clinical level.
    Wyatt RJ; Cannon EH; Stoff DM; Gillin JC
    Ann N Y Acad Sci; 1976; 281():456-86. PubMed ID: 828469
    [No Abstract]   [Full Text] [Related]  

  • 16. "In vivo biosynthesis of N,N-dimethyltryptamine, 5-MeO-N,N-dimethyltryptamine, and bufotenine in E.coli".
    Friedberg LM; Sen AK; Nguyen Q; Tonucci GP; Hellwarth EB; Gibbons WJ; Jones JA
    Metab Eng; 2023 Jul; 78():61-71. PubMed ID: 37230161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hallucinogens as discriminative stimuli: a comparison of 4-OMe DMT and 5-OMe DMT with their methythio counterparts.
    Glennon RA; Young R; Benington F; Morin RD
    Life Sci; 1982 Feb; 30(5):465-7. PubMed ID: 6801410
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hallucinogen-induced rotational behavior in rats.
    Fleisher LN; Glick SD
    Psychopharmacology (Berl); 1979 Apr; 62(2):193-200. PubMed ID: 111284
    [No Abstract]   [Full Text] [Related]  

  • 19. Evidence from behavioural reactions to fenfluramine, 5-hydroxytryptophan, and 5-methoxy-N,N-dimethyltryptamine for differential effects of short-term and long-term lithium on indoleaminergic mechanisms in rats [proceedings].
    Harrison-Read PE
    Br J Pharmacol; 1979 May; 66(1):144P-145P. PubMed ID: 313227
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of N,N-dimethyltryptamine on behavioural habituation in the rat.
    File SE
    Pharmacol Biochem Behav; 1977 Feb; 6(2):163-8. PubMed ID: 266219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.